Clinical Research Directory
Browse clinical research sites, groups, and studies.
Benefits of Smart Pens in Type 1 Diabetes
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Summary
This study aims to address persistent challenges in achieving recommended control goals for patients with type 1 diabetes through innovative interventions. Specifically, the research focuses on assessing the effectiveness of smart insulin pens combined with glucose monitoring devices as a promising treatment option for individuals on multiple daily insulin injections. The study will analyze electronic health records from adults (≥ 18 years) attending the Diabetes Unit of the University Clinical Hospital of Valencia. Participants who are or have used smart insulin pens will be compared with a control group matched for age, sex, duration of diabetes, and HbA1c value at baseline (1:1). Data will be collected on participant characteristics, smart pen usage, glycemic control parameters, and daily insulin doses. The study also aims to identify adverse events associated with the use of smart pens. Ethical considerations include ensuring the anonymity of participant data, and the study is designed to comply with European (EU) data protection regulations. The retrospective nature ensures no interference with physicians' prescription habits.
Official title: Benefits of Smart Pens in People With Type 1 Diabetes: a Real-word Retrospective Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-07
Completion Date
2024-12
Last Updated
2024-05-16
Healthy Volunteers
No
Conditions
Interventions
Insulin Smart Pen
Retrospective analysis of electronic health records for individuals with type 1 diabetes receiving multiple daily doses of insulin, combined with glucose monitoring devices and who have used or are currently using insulin smart pens.
Locations (1)
INCLIVA
Valencia, Spain